35253615|t|Celastrol, a TFEB (transcription factor EB) agonist, is a promising drug candidate for Alzheimer disease.
35253615|a|Alzheimer disease (AD) is the most common neurodegenerative disease. Unfortunately, current effective therapeutics for AD are limited and thus the discovery of novel anti-AD agents is urgently needed. A key pathological hallmark of AD is the accumulation of phosphorylated MAPT/tau (microtubule associated protein tau) aggregates to form neurofibrillary tangles. Autophagy is a conserved catabolic process that degrades protein aggregates or organelles via lysosomes. TFEB (transcription factor EB), a master regulator of autophagy, transcriptionally regulates multiple autophagy, and lysosomal-related genes. A compromised autophagy-lysosomal pathway (ALP) has been implicated in AD progression, and enhancing TFEB-mediated ALP to degrade MAPT/tau aggregates is a promising anti-AD strategy. In a recent study, we showed that celastrol, a natural small molecule with an anti-obesity effect, is a novel TFEB activator, which enhances autophagy and lysosomal biogenesis both in vitro and in animal brains. Consequently, celastrol promotes the degradation of phosphorylated MAPT/tau aggregates both in cells and in the brain of P301S MAPT/tau and 3XTg mice, two commonly used AD animal models. Interestingly, celastrol also alleviates memory deficits in these mice. Altogether, celastrol enhances TFEB-mediated autophagy and lysosomal biogenesis to ameliorate MAPT/tau pathology, suggesting that celastrol represents a novel anti-AD and other tauopathies drug candidate.Abbreviations: AD: Alzheimer disease; ALP: autophagy-lysosomal pathway; MAPT/tau: microtubule-associated protein tau; MTORC1: mechanistic target of rapamycin kinase complex 1; TFEB: transcription factor EB.
35253615	0	9	Celastrol	Chemical	MESH:C050414
35253615	13	17	TFEB	Gene	21425
35253615	19	42	transcription factor EB	Gene	21425
35253615	87	104	Alzheimer disease	Disease	MESH:D000544
35253615	106	123	Alzheimer disease	Disease	MESH:D000544
35253615	125	127	AD	Disease	MESH:D000544
35253615	148	173	neurodegenerative disease	Disease	MESH:D019636
35253615	225	227	AD	Disease	MESH:D000544
35253615	277	279	AD	Disease	MESH:D000544
35253615	338	340	AD	Disease	MESH:D000544
35253615	389	423	microtubule associated protein tau	Gene	17762
35253615	444	467	neurofibrillary tangles	Disease	MESH:D055956
35253615	574	578	TFEB	Gene	21425
35253615	580	603	transcription factor EB	Gene	21425
35253615	787	789	AD	Disease	MESH:D000544
35253615	817	821	TFEB	Gene	21425
35253615	886	888	AD	Disease	MESH:D000544
35253615	933	942	celastrol	Chemical	MESH:C050414
35253615	982	989	obesity	Disease	MESH:D009765
35253615	1009	1013	TFEB	Gene	21425
35253615	1125	1134	celastrol	Chemical	MESH:C050414
35253615	1232	1237	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;OriginalGene:17762;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:10090;CA#:225439
35253615	1256	1260	mice	Species	10090
35253615	1280	1282	AD	Disease	MESH:D000544
35253615	1313	1322	celastrol	Chemical	MESH:C050414
35253615	1339	1354	memory deficits	Disease	MESH:D008569
35253615	1364	1368	mice	Species	10090
35253615	1382	1391	celastrol	Chemical	MESH:C050414
35253615	1401	1405	TFEB	Gene	21425
35253615	1500	1509	celastrol	Chemical	MESH:C050414
35253615	1534	1536	AD	Disease	MESH:D000544
35253615	1547	1558	tauopathies	Disease	MESH:D024801
35253615	1589	1591	AD	Disease	MESH:D000544
35253615	1593	1610	Alzheimer disease	Disease	MESH:D000544
35253615	1656	1690	microtubule-associated protein tau	Gene	17762
35253615	1692	1698	MTORC1	Gene	18392
35253615	1750	1754	TFEB	Gene	21425
35253615	1756	1779	transcription factor EB	Gene	21425
35253615	Negative_Correlation	MESH:C050414	MESH:D000544
35253615	Positive_Correlation	MESH:C050414	21425
35253615	Association	MESH:D055956	17762
35253615	Association	MESH:D000544	21425
35253615	Negative_Correlation	MESH:C050414	MESH:D008569
35253615	Association	MESH:D000544	17762
35253615	Negative_Correlation	MESH:C050414	MESH:D024801
35253615	Negative_Correlation	MESH:C050414	MESH:D009765

